{"id":"W4387750398","doi":"10.14309/01.ajg.0000953092.75630.8f","title":"S863 Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Bio-naïve Patients With Late Crohn’s Disease: Results from the EVOLVE Expansion Study","year":2023,"lang":"en","type":"article","venue":"The American Journal of Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Thermo Fisher Scientific (Canada); St. Paul's Hospital","funders":"","keywords":"Medicine; Vedolizumab; Ustekinumab; Discontinuation; Internal medicine; Adverse effect; Hazard ratio; Crohn's disease; Surgery; Disease; Adalimumab; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00732153,0.0002829357,0.00103132,0.0004093998,0.0002430993,0.0009658571,0.0003470431,0.0004197181,0.001743472],"category_scores_gemma":[0.007715196,0.0001555616,0.001507039,0.0008686669,0.0003868304,0.0005509292,0.0005777276,0.0004504905,0.0002572562],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005944907,"about_ca_system_score_gemma":0.0009508908,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001161762,"about_ca_topic_score_gemma":0.002214088,"domain_scores_codex":[0.9958706,0.002390536,0.000512454,0.0003191505,0.0007751052,0.0001320739],"domain_scores_gemma":[0.9887543,0.003876148,0.005203629,0.0006420381,0.0009438325,0.0005801598],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.07390272,0.001869518,0.8338701,0.001825831,0.005068435,0.0001857843,0.000360288,0.001611011,0.002637947,0.0002738886,0.003085975,0.07530865],"study_design_scores_gemma":[0.01189755,0.01647845,0.9583369,0.0004472544,0.002476959,0.0005558885,0.0001820801,0.001939647,0.001591528,0.0001817345,0.005870244,0.00004178757],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917212,0.002868838,0.0002333426,0.000150311,0.0000171359,0.0001904456,0.003386028,0.00001171469,0.001420983],"genre_scores_gemma":[0.9917079,0.0007523516,0.0006520543,0.0002814428,0.00007435023,0.0002546033,0.005937099,0.000006233919,0.0003339763],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00732153,"threshold_uncertainty_score":0.03872043,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008543027945766817,"score_gpt":0.2721175414709764,"score_spread":0.2635745135252096,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}